BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33941559)

  • 1. Exploring Potential Biomarkers Underlying the Pathogenesis of Alzheimer's Disease by Bioinformatics Gene Analysis.
    Ma X; Meng G; Zhang M; Zhao Y; Zhou Y; Zhao Y; Liu X
    Ann Clin Lab Sci; 2021 Mar; 51(2):198-205. PubMed ID: 33941559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of therapeutic targets for Alzheimer's disease via differentially expressed gene and weighted gene co-expression network analyses.
    Jia Y; Nie K; Li J; Liang X; Zhang X
    Mol Med Rep; 2016 Nov; 14(5):4844-4848. PubMed ID: 27748870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human microRNA-4433 (hsa-miR-4443) Targets 18 Genes to be a Risk Factor of Neurodegenerative Diseases.
    Ge X; Yao T; Zhang C; Wang Q; Wang X; Xu LC
    Curr Alzheimer Res; 2022; 19(7):511-522. PubMed ID: 35929619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Biomarkers Associated With Alzheimer's Disease by Bioinformatics Analysis.
    Zhao Y; Tan W; Sheng W; Li X
    Am J Alzheimers Dis Other Demen; 2016 Mar; 31(2):163-8. PubMed ID: 26082458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Bioinformatic Analysis of the Dysregulated Genes and MicroRNAs in Entorhinal Cortex, Hippocampus, and Blood for Alzheimer's Disease.
    Pang X; Zhao Y; Wang J; Zhou Q; Xu L; Kang D; Liu AL; Du GH
    Biomed Res Int; 2017; 2017():9084507. PubMed ID: 29359159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of microRNA-mRNA Regulatory Networks with Therapeutic Values in Alzheimer's Disease by Bioinformatics Analysis.
    Kavoosi S; Shahraki A; Sheervalilou R
    J Alzheimers Dis; 2024; 98(2):671-689. PubMed ID: 38427479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
    Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
    J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Early-Onset Preeclampsia-Related Genes and MicroRNAs by Bioinformatics Approaches.
    Song J; Li Y; An RF
    Reprod Sci; 2015 Aug; 22(8):954-63. PubMed ID: 25717061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three hematologic/immune system-specific expressed genes are considered as the potential biomarkers for the diagnosis of early rheumatoid arthritis through bioinformatics analysis.
    Cheng Q; Chen X; Wu H; Du Y
    J Transl Med; 2021 Jan; 19(1):18. PubMed ID: 33407587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatic Analysis of Potential microRNAs in Ischemic Stroke.
    He W; Chen S; Chen X; Li S; Chen W
    J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1753-1759. PubMed ID: 27151415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-Wide Profiling of miRNA and mRNA Expression in Alzheimer's Disease.
    Chang WS; Wang YH; Zhu XT; Wu CJ
    Med Sci Monit; 2017 Jun; 23():2721-2731. PubMed ID: 28578378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of microRNA and Gene Expression Profiles in Alzheimer's Disease: A Meta-Analysis Approach.
    Moradifard S; Hoseinbeyki M; Ganji SM; Minuchehr Z
    Sci Rep; 2018 Mar; 8(1):4767. PubMed ID: 29555910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
    Zhou J; Hui X; Mao Y; Fan L
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated approach to unravel a putative crosstalk network in Alzheimer's disease and Parkinson's disease.
    Bisht I; Ambasta RK; Kumar P
    Neuropeptides; 2020 Oct; 83():102078. PubMed ID: 32807513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification for Exploring Underlying Pathogenesis and Therapy Strategy of Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
    Xu Z; Jiang P; He S
    Med Sci Monit; 2019 Dec; 25():9216-9226. PubMed ID: 31794546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network-based approach to identify molecular signatures and therapeutic agents in Alzheimer's disease.
    Rahman MR; Islam T; Turanli B; Zaman T; Faruquee HM; Rahman MM; Mollah MNH; Nanda RK; Arga KY; Gov E; Moni MA
    Comput Biol Chem; 2019 Feb; 78():431-439. PubMed ID: 30606694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of molecular signatures and pathways to identify novel therapeutic targets in Alzheimer's disease: Insights from a systems biomedicine perspective.
    Rahman MR; Islam T; Zaman T; Shahjaman M; Karim MR; Huq F; Quinn JMW; Holsinger RMD; Gov E; Moni MA
    Genomics; 2020 Mar; 112(2):1290-1299. PubMed ID: 31377428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA expression data analysis to identify key miRNAs associated with Alzheimer's disease.
    Chen J; Qi Y; Liu CF; Lu JM; Shi J; Shi Y
    J Gene Med; 2018 Jun; 20(6):e3014. PubMed ID: 29543360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential therapeutic target genes, key miRNAs and mechanisms in oral lichen planus by bioinformatics analysis.
    Gong C; Sun S; Liu B; Wang J; Chen X
    Arch Oral Biol; 2017 Jun; 78():122-128. PubMed ID: 28237528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.